Increased malondialdehyde vs. reduced sirtuin 1 in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.

Rkhaya, Samar Abu; Bulatova, Nailya; Kasabri, Violet; Naffa, Randa; Alquoqa, Reema

Rkhaya, Samar Abu; Bulatova, Nailya; Kasabri, Violet; Naffa, Randa; Alquoqa, Reema.

Afiliação

Rkhaya SA; Schools of Pharmacy and Medicine, University of Jordan, Queen Rania Street, Amman, 11942, Jordan.
Bulatova N; Schools of Pharmacy and Medicine, University of Jordan, Queen Rania Street, Amman, 11942, Jordan.
Kasabri V; Schools of Pharmacy and Medicine, University of Jordan, Queen Rania Street, Amman, 11942, Jordan. Electronic address: hotice162@gmail.com.
Naffa R; Schools of Pharmacy and Medicine, University of Jordan, Queen Rania Street, Amman, 11942, Jordan.
Alquoqa R; Schools of Pharmacy and Medicine, University of Jordan, Queen Rania Street, Amman, 11942, Jordan.

Diabetes Metab Syndr ; 12(6): 903-909, 2018 Nov.

Article em En | MEDLINE | ID: mdl-29779969

Assuntos

Malondialdeído/sangue; Síndrome Metabólica/sangue; Estado Pré-Diabético/sangue; Sirtuína 1/sangue; Adulto; Estudos de Casos e Controles; Estudos Transversais; Feminino; Humanos; Masculino; Síndrome Metabólica/complicações; Pessoa de Meia-Idade; Estado Pré-Diabético/etiologia

Palavras-chave

Adiposity indices; Atherogenicity indices; Hematology indices; Malondialdehyde; Metabolic syndrome; Sirtuin1; Type 2 diabetes mellits

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Síndrome Metabólica / Sirtuína 1 / Malondialdeído Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google